Ibrutinib-associated ventricular arrhythmia in the FDA Adverse Event Reporting System.

HOME
>
論文・技術情報
>
Ibrutinib-associated ventricular arrhythmia in the FDA Adverse Event Reporting System.

アブストラクト
ジャーナル名	Leukemia & lymphoma
Pubmed追加日	2018/5/25
投稿者	Cheng, Connie; Woronow, Daniel; Nayernama, Afrouz; Wroblewski, Tanya; Jones, S Christopher
組織名	a Division of Pharmacovigilance, Office of Surveillance and Epidemiology , Center;for Drug Evaluation and Research, U.S. Food and Drug Administration , Silver;Spring , MD , USA.;b Division of Hematology Products, Office of Hematology and Oncology Products ,;Center for Drug Evaluation and Research, U.S. Food and Drug Administration ,;Silver Spring , MD , USA.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/29792382/